Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Alimentary Pharmacology & Therapeutics|May 22, 2004
Outcome of emergency ERCP for acute cholangitis in patients 90 years of age and olderC-K Hui, C-L Liu, K-C Lai, et al.
Gut|September 18, 2002
Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patientsW M Wong, B C Y Wong, W K Hung, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese populationH H-X Xia, B C Y Wong, W M Wong, et al.
The Medical Journal of Australia|May 26, 2018
Hyperglycaemia in early pregnancy: the Treatment of Booking Gestational diabetes Mellitus (TOBOGM) study. A randomised controlled trialDavid Simmons, William M Hague, Helena J Teede, et al.
Alimentary Pharmacology & Therapeutics|June 6, 2003
A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese populationW M Wong, K F Lam, K C Lai, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 11, 2002
Normal 24-hour ambulatory proximal and distal gastroesophageal reflux parameters in ChineseW H C Hu, N Y H Wong, K C Lai, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2004
Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux diseaseW M Wong, K C Lai, W M Hui, et al.
Alimentary Pharmacology & Therapeutics|November 18, 2003
A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese populationB C-Y Wong, W M Wong, K L Cheung, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2001
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled studyB C Wong, W H Wang, W M Wong, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infectionB C Wong, W M Wong, Y K Yee, et al.
Pageof 14